The Lenacapavir is an injectable HIV prevention method that has been recently approved for administration twice per year. According to research carried out, the Lenacapavir injection has been shown to work effectively in preventing HIV infections in young women, making it a big breakthrough in HIV prevention. Unfortunately, the prohibitive cost, patents, and lack of generic forms of the drug that are less costly will prevent many people from using it in poor and developing countries.